pteropin
orthoreoviru
prv
emerg
batborn
human
pathogen
caus
sever
respiratori
ill
date
howev
evalu
prv
virul
larg
depend
limit
number
clinic
case
owe
lack
anim
model
develop
vivo
model
prv
infect
inbr
mous
strain
infect
intranas
pathogen
prv
strain
mice
suffer
sever
lung
infect
signific
bodi
weight
reduct
die
within
day
intranas
infect
infecti
virus
isol
mainli
lung
trachea
histopatholog
examin
reveal
interstiti
pneumonia
monocyt
infiltr
follow
repeat
intranas
infect
mice
develop
antibodi
particular
structur
nonstructur
protein
prv
result
immunolog
assay
help
develop
laboratori
protocol
seroepidemiolog
studi
small
rodent
model
lethal
respiratori
infect
allow
investig
molecular
mechan
underli
high
pathogen
prv
pteropin
orthoreoviru
prv
member
famili
reovirida
genu
orthoreoviru
prototyp
strain
prv
first
isol
fli
fox
pteropu
poliocephalu
nelson
bay
australia
gard
compan
gard
marshal
prv
sole
member
compris
prv
group
consider
period
second
case
prv
strain
pulau
report
bat
speci
malaysia
pritchard
et
al
first
human
case
prv
infect
prv
strain
melaka
report
malaysia
patient
high
fever
respiratori
diseas
chua
et
al
sinc
first
case
prv
infect
human
evid
prv
infect
human
cheng
et
al
chua
et
al
chua
et
al
chua
et
al
voon
et
al
wong
et
al
yamanaka
et
al
bat
du
et
al
hu
et
al
lorusso
et
al
associ
southeast
asian
nation
asean
countri
china
report
phylogenet
studi
show
genet
close
relationship
prv
strain
human
bat
origin
impli
prv
batborn
zoonos
chua
et
al
particular
one
prvinfect
patient
histori
close
contact
bat
onset
ill
chua
et
al
epidemiolog
situat
support
hypothesi
patient
might
obtain
infect
bat
howev
direct
evid
show
connect
bat
human
regard
prv
transmiss
seroepidemiolog
studi
report
sera
patient
visit
hospit
vietnam
healthi
volunt
malaysia
seroposit
prv
chua
et
al
singh
et
al
furthermor
recent
epidemiolog
studi
base
pcr
detect
prv
genom
patient
acut
upper
respiratori
tract
infect
indic
prv
consid
common
pathogen
asean
countri
caus
mild
respiratori
infect
voon
et
al
taken
togeth
report
suggest
prv
evolv
cross
speci
barrier
bat
human
commerci
small
anim
model
includ
mice
guinea
pig
commonli
util
primari
diseas
model
infecti
diseas
previous
studi
pathogen
prv
infect
human
evalu
base
limit
number
human
infect
case
owe
lack
experiment
anim
model
experiment
infect
prv
limit
primari
trial
use
prv
strain
nelson
bay
gard
marshal
inocul
suckl
mice
kill
intracrani
infect
experi
howev
obvious
dissoci
spontan
respiratori
infect
human
report
prv
infect
central
nervou
system
howev
sinc
first
report
human
case
prv
infect
anim
model
prv
infect
reflect
human
respiratori
infect
develop
report
lethal
lung
infect
model
prv
strain
mb
isol
patient
acut
respiratori
infect
yamanaka
et
al
adult
immunocompet
inbr
mice
identifi
signific
differ
suscept
prv
infect
mous
strain
intranas
infect
caus
lethal
outcom
sever
pneumonia
wherea
oral
infect
establish
suggest
prv
airborn
transmiss
pathogen
addit
mice
repeatedli
infect
prv
develop
antibodi
particular
viral
protein
serolog
inform
contribut
develop
protocol
seroepidemiolog
studi
serodiagnosi
furthermor
anim
model
pathogen
prv
infect
provid
crucial
opportun
understand
viru
pathogenesi
evalu
vaccin
therapeut
combat
import
pathogen
mous
fibroblast
lung
adenocarcinoma
rhesu
monkey
kidney
cell
line
grown
dulbecco
modifi
eagl
medium
dmem
nacalai
tesqu
supplement
fetal
bovin
serum
gibco
quail
fibrosarcoma
cell
line
grown
dmem
supplement
fetal
calf
serum
prv
strain
mb
yamanaka
et
al
amplifi
cell
approxim
concentr
viru
stock
gener
use
polyethylen
glycol
concentr
method
describ
elsewher
lewi
metcalf
infecti
viru
titer
determin
plaqu
assay
kawagishi
et
al
avian
reoviru
strain
takas
et
al
simian
rotaviru
strain
taniguchi
et
al
mammalian
orthoreoviru
prototyp
strain
amplifi
cell
respect
virus
inocul
cell
absorb
h
cultur
medium
replac
fresh
medium
incub
h
post
infect
cell
fix
ethanol
infect
cell
visual
immunostain
use
antiserum
prv
strain
mb
dilut
incub
min
follow
alexa
flour
conjug
antimous
igg
second
antibodi
dilut
invitrogen
polyclon
rabbit
antiserum
prepar
sigma
aldrich
purifi
histag
prv
strain
mb
protein
obtain
bacteri
cultur
brief
strain
mb
gene
insert
ptrchisa
plasmid
thermo
fisher
scientif
enabl
express
tag
recombin
protein
plasmid
construct
use
transform
escherichia
coli
strain
thermo
fisher
scientif
protein
express
induc
ad
mm
isopropyl
bacteri
pellet
lyse
millipor
target
protein
purifi
use
select
nickel
affin
gel
sigma
aldrich
accord
manufactur
instruct
purchas
fourweek
old
male
mice
charl
river
laboratori
fourweek
old
male
jcl
icr
icr
balb
cajcl
balbc
mice
japan
clea
anim
inocul
intranas
oral
viru
respect
obtain
kaplanmei
surviv
curv
anim
observ
dpi
bodi
weight
record
everi
day
surviv
mice
intranas
infect
prv
strain
mb
pfu
mix
infect
intranas
pfu
total
infect
obtain
antisera
defin
extent
viral
replic
mous
organ
anim
sacrif
day
intranas
infect
organ
disrupt
repeat
freezethaw
cycl
time
follow
homogen
use
bead
homogen
beadsmash
waken
btech
co
ltd
serum
separ
whole
blood
clot
centrifug
g
viru
titer
organ
sera
determin
plaqu
assay
patholog
studi
mice
infect
intranas
pfu
prv
strain
mb
sacrif
day
organ
fix
buffer
formaldehyd
process
patholog
examin
includ
stain
ihc
analysi
use
antiserum
studi
approv
anim
research
committe
research
institut
microbi
diseas
osaka
univers
experi
conduct
follow
guidelin
care
use
laboratori
anim
ministri
educ
cultur
sport
scienc
technolog
japan
inflammatori
cytokin
level
blood
examin
use
quantikin
elisa
kit
r
system
accord
manufactur
instruct
neutral
antibodi
titer
sera
examin
neutral
assay
brief
serial
dilut
sera
dmem
prepar
micropl
equal
volum
viru
fluid
ad
incub
min
co
incub
posit
control
virus
mix
equal
volum
dmem
incub
neutral
virus
inocul
onto
monolay
micropl
incub
h
cell
fix
absolut
ethanol
cell
express
viral
antigen
detect
use
murin
antiprv
strain
mb
antibodi
kawagishi
et
al
goat
antimous
igg
antibodi
conjug
nt
titer
indic
reciproc
valu
maximum
dilut
number
foci
show
reduct
compar
posit
control
nt
assay
mrv
rv
arv
perform
similarli
although
viru
titrat
measur
plaqu
assay
briefli
mrv
rv
arv
incub
serial
dilut
sera
inocul
cell
respect
overlaid
agaros
gel
plaqu
number
compar
control
sampl
neutral
titer
reduct
calcul
nt
titer
express
mean
confid
interv
ci
ci
calcul
accord
follow
formula
sd
standard
deviat
n
sampl
number
immunolog
assay
express
plasmid
vector
ntermin
flagtag
prv
protein
construct
gene
encod
viral
protein
includ
amplifi
rtpcr
use
specif
primer
base
sequenc
deposit
genbank
access
number
amplifi
pcr
product
fuse
flag
epitop
tag
nterminu
clone
pef
plasmid
vector
mizushima
nagata
plasmid
confirm
dna
sequenc
primer
sequenc
use
plasmid
construct
avail
upon
request
nativ
protein
known
degrad
rapidli
synthesi
shmulevitz
et
al
thu
mutant
val
arg
amino
acid
substitut
posit
gener
achiev
increas
express
level
cheng
et
al
viral
gene
prv
protein
amplifi
pcr
use
specif
primer
insert
pcag
plasmid
express
vector
enabl
express
hatag
prv
protein
mammalian
cell
express
plasmid
transfect
cell
h
post
infect
cell
lyse
sodium
dodecyl
sulfat
sd
fix
ethanol
wb
ffa
respect
wb
sampl
appli
sdspolyacrylamid
gel
electrophoresi
page
except
viral
protein
appli
sdspage
blot
membran
viral
protein
detect
use
dilut
antisera
prv
develop
repeat
intranas
infect
ffa
cell
transfect
hatag
prv
protein
fix
formalin
h
post
transfect
viral
protein
visual
dilut
mous
serum
antiha
antibodi
develop
rabbit
follow
antimous
conjug
antirabbit
respect
prv
infect
accompani
sever
respiratori
symptom
human
tan
et
al
suggest
infect
prv
like
occur
mainli
via
intranas
rout
airborn
viru
particl
develop
mous
model
respiratori
prv
infect
inbr
mice
male
infect
pathogen
prv
strain
mb
yamanaka
et
al
via
intranas
rout
pfuhead
mice
show
bodi
weight
decreas
day
postinfect
dpi
first
death
occur
dpi
fig
b
mous
group
receiv
highest
infect
dose
pfuhead
led
mortal
follow
fig
contrast
group
challeng
oral
viru
maximum
dose
pfu
mice
surviv
bodi
weight
reduct
fig
next
dynam
viru
distribut
investig
follow
intranas
infect
lethal
dose
pfu
prv
strain
mb
mice
expect
clinic
symptom
prv
infect
human
respiratori
organ
constitut
major
site
viru
propag
time
point
fig
dpi
infecti
virus
detect
lung
mg
trachea
mg
liver
mg
especi
lung
high
titer
prv
detect
throughout
infect
fig
liver
small
number
virus
near
detect
limit
detect
dpi
limit
quantiti
infecti
virus
mg
found
ileum
oral
infect
fig
suggest
oral
prv
infect
lead
ineffici
viral
spread
gastrointestin
system
assess
inflammatori
cytokinechemokin
induct
prv
infect
measur
immun
respons
symptom
gener
examin
level
interferon
induc
inflammatori
chemokin
induc
variou
viru
infect
level
blood
anim
infect
intranas
peak
dpi
follow
subsequ
decreas
day
mice
oral
infect
prv
blood
increas
slightli
dpi
soon
decreas
baselin
level
dpi
fig
level
blood
consist
viral
load
mice
intranas
oral
infect
prv
suggest
may
serv
index
predict
acut
infect
prv
also
investig
sensit
mous
strain
includ
balbc
icr
prv
infect
balbc
icr
mice
infect
lethal
dose
mice
pfu
via
intranas
rout
among
three
strain
icr
mice
sensit
prv
infect
rel
high
mortal
slight
bodi
weight
reduct
fig
b
although
balbc
mice
exhibit
greater
reduct
bodi
weight
icr
mice
mortal
two
mice
strain
balbc
lower
icr
mice
data
indic
mous
strain
sensit
prv
infect
among
four
mice
strain
test
constitut
suitabl
anim
model
investig
pathogen
respiratori
prv
infect
histopatholog
examin
conduct
lung
mice
infect
intranas
pfu
prv
strain
mb
dpi
mice
sacrif
trachea
lung
small
intestin
larg
intestin
spleen
sampl
lung
infect
mice
demonstr
focal
hemorrhag
entir
organ
fig
hematoxylin
eosin
stain
reveal
interstiti
pneumonia
decidu
bronchial
epitheli
cell
thicken
intraalveolar
septum
accompani
infiltr
inflammatori
monocyt
fig
c
immunohistochem
ihc
analys
use
antiserum
reveal
cell
tropism
prv
infect
viral
antigen
found
tracheal
epitheli
cell
alveolar
cell
appear
compris
type
ii
alveolar
epitheli
cell
fig
e
posit
signal
seen
uninfect
control
mous
sampl
demonstr
specif
antibodi
use
ihc
examin
fig
g
previou
studi
demonstr
prv
strain
mb
induc
syncytium
format
infect
cultur
cell
yamanaka
et
al
kawagishi
et
al
howev
despit
extens
examin
hestain
ihcstain
sampl
sign
cellcel
fusion
observ
lung
section
assess
antiprv
humor
immun
respons
first
investig
neutral
antibodi
activ
induc
mice
infect
prv
strain
mb
mice
surviv
intranas
infect
pfu
challeng
intranas
infect
pfu
time
week
interv
total
infect
two
week
final
infect
infect
anim
sacrif
sera
separ
previou
studi
indic
prv
cell
attach
protein
requir
entri
cell
entri
cell
kawagishi
et
al
perform
nt
assay
use
cell
line
mice
intranas
infect
prv
induc
specif
neutral
antibodi
prv
nt
assay
conduct
cell
tabl
wherea
nt
titer
time
lower
experi
conduct
cell
result
suggest
candid
cell
line
appropri
nt
assay
prv
infect
investig
crossnt
activ
prv
relat
virus
famili
reovirida
mrv
rv
common
human
pathogen
major
adult
possess
antibodi
mrv
rv
nt
assay
use
antiprv
serum
mrv
rv
demonstr
nt
activ
antiprv
serum
specif
prv
neutral
mrv
rv
antiprv
serum
also
neutral
arv
member
famili
reovirida
indic
prv
serolog
independ
common
human
anim
reovirus
tabl
result
nt
test
suggest
antibodi
mrv
rv
contribut
protect
prv
infect
final
examin
induc
antibodi
prv
protein
mice
gener
intranas
prv
infect
specif
antibodi
reaction
prv
antigen
firstli
investig
ffa
use
cell
express
prv
structur
nonstructur
protein
ffa
clear
reaction
outer
capsid
protein
two
inner
capsid
protein
two
nonstructur
protein
compon
viral
inclus
bodi
fig
tabl
product
antibodi
prv
protein
confirm
western
blot
wb
wb
mous
serum
react
fewer
number
viral
protein
compar
ffa
assay
includ
fig
tabl
result
suggest
immunofluoresc
assay
use
cell
infect
prv
fig
pathogen
prv
small
rodent
model
balbc
icr
mice
old
male
infect
pfu
prv
strain
mb
intranas
bodi
weight
surviv
rate
b
record
daili
data
express
mean
sd
n
dryden
et
al
dryden
et
al
trask
et
al
b
antiprv
serum
intranas
infect
prv
strain
mb
use
ffa
hatag
recombin
prv
protein
express
cell
antiha
antibodi
use
posit
control
conjug
secondari
antibodi
use
detect
antiprv
antiha
antibodi
respect
mutant
protein
mutant
use
instead
wildtyp
effici
detect
express
particular
prv
protein
may
repres
appropri
method
seroepidemiolog
studi
prv
develop
anim
model
would
facilit
studi
prv
pathogen
establish
small
anim
model
lethal
prv
lung
infect
use
matur
immunocompet
inbr
mice
fig
phylogenet
analysi
impli
genet
relat
prv
strain
transmit
bat
human
howev
direct
evid
precis
transmiss
rout
prv
thu
understand
transmiss
prv
differ
infect
rout
intranas
oral
test
subsequ
examin
viru
distribut
intranas
infect
patholog
examin
confirm
prv
preferenti
infect
respiratori
organ
sever
damag
respiratori
organ
intranas
infect
observ
mice
indic
prv
infect
mous
similar
clinic
case
prv
infect
human
fig
togeth
evid
indic
prv
airborn
transmiss
diseas
low
level
viremia
prvinfect
mice
might
suggest
viru
transmit
arthropod
vector
although
human
prv
infect
case
exclus
exhibit
respiratori
symptom
prv
isol
bat
detect
variou
sampl
includ
saliva
fece
lorusso
et
al
blood
gard
marshal
urin
pritchard
et
al
lung
homogen
du
et
al
intestin
content
hu
et
al
indic
patholog
prv
infect
bat
dissimilar
human
infect
howev
inform
regard
tissu
tropism
prv
bat
avail
bat
known
naturel
reservoir
numer
zoonot
virus
includ
highli
pathogen
virus
filovirus
rabi
virus
nipahvirus
coronavirus
calish
et
al
import
bat
reservoir
zoonot
virus
character
featur
bat
often
permit
persist
infect
highli
pathogen
virus
without
present
symptom
known
whether
prv
caus
pathogen
respiratori
infect
bat
could
conclud
studi
whether
mous
model
reflect
prv
infect
bat
patholog
studi
regard
prv
infect
bat
would
requir
better
understand
prv
spread
transmiss
natur
viral
infect
induc
inflammatori
cytokin
chemokin
two
opposit
role
host
defens
symptom
format
thu
serv
import
indic
predict
viru
infect
grebe
et
al
guidotti
chisari
melchjorsen
et
al
howev
report
regard
cytokin
induct
prv
infect
particular
inflammatori
chemokin
induc
variou
viru
infect
recruit
activ
tcell
site
inflamm
liu
et
al
current
studi
found
level
blood
correl
viral
load
mice
intranas
oral
infect
prv
suggest
serv
index
predict
acut
prv
infect
among
four
mous
strain
examin
current
studi
strain
sensit
prv
infect
fig
viru
studi
also
report
highli
sensit
sendai
fourweek
old
male
mice
infect
pfu
prv
strain
mb
follow
intranas
infect
pfu
prv
week
interv
anim
sacrif
week
last
infect
sera
separ
wb
analysi
hatag
recombin
viral
protein
express
cell
perform
neighbour
et
al
niewiesk
et
al
parker
et
al
wherea
mous
strain
resist
murin
hepat
viru
murin
cytomegaloviru
allan
shellam
bang
warwick
mechan
underli
differ
suscept
virus
consid
due
differ
immun
respons
presenc
viru
bind
receptor
although
evid
explain
highest
suscept
mice
prv
infect
analysi
regard
differ
suscept
among
mous
strain
ie
vs
icr
balbc
would
help
understand
molecular
mechan
prv
pathogen
particular
genet
background
host
influenc
outcom
prv
replic
pathogenesi
note
young
male
mice
includ
studi
although
prv
detect
exclus
adult
patient
year
old
cheng
et
al
chua
et
al
chua
et
al
chua
et
al
wong
et
al
yamanaka
et
al
note
mice
immunolog
matur
jackson
et
al
explor
associ
mous
model
natur
infect
studi
requir
employ
femal
mice
mice
wider
age
rang
sign
cellcel
fusion
infect
lung
tissu
observ
result
suggest
prv
strain
mb
induc
syncytium
format
vivo
disrupt
damag
cell
make
difficult
identifi
cellcel
fusion
target
tissu
use
mice
sera
infect
prv
serolog
examin
conduct
investig
whether
prv
antibodi
contribut
protect
genet
relat
reovirida
virus
includ
arv
mrv
rv
result
nt
test
demonstr
prv
serolog
independ
virus
although
arv
mrv
rvspecif
antisera
test
investig
regard
whether
prv
infect
crossneutr
antibodi
reovirida
virus
would
help
understand
epidemiolog
prv
furthermor
signific
differ
nt
assay
result
prv
cell
could
explain
differ
usag
viral
ligand
cell
attach
prv
infect
recent
demonstr
prv
util
viru
structur
protein
entri
cell
kawagishi
et
al
nt
assay
use
cell
antibodi
serum
mice
infect
prv
work
effect
neutral
antibodi
cell
shown
fig
compris
one
major
viral
protein
induc
specif
antibodi
thu
reason
high
amount
neutral
antibodi
infect
mice
sera
caus
high
nt
activ
cell
could
conclud
cell
could
therefor
recommend
nt
assay
seroepidemiolog
studi
prv
comparison
signific
differ
reactiv
serum
viral
protein
ffa
wb
assay
gener
antibodi
reactiv
ffa
recogn
conform
epitop
wherea
reactiv
wb
recogn
linear
epitop
owe
differ
method
use
sampl
prepar
present
studi
mous
serum
react
quit
high
titer
ffa
assay
reactiv
wb
assay
probabl
occur
antibodi
like
recogn
conform
epitop
linear
epitop
ffa
wb
assay
fairli
strong
reaction
observ
protein
locat
surfac
virion
function
cellattach
viral
protein
reason
antibodi
induc
protein
known
highli
variabl
prv
isol
probabl
neutral
antibodi
pressur
might
drive
rapid
mutat
protein
owe
high
variat
sequenc
may
therefor
repres
appropri
target
seroepidemiolog
studi
broad
rang
prv
strain
may
instead
suitabl
detect
specif
viru
strain
contrast
viral
protein
induc
specif
antibodi
includ
six
structur
protein
two
nonstructur
protein
rel
conserv
prv
isol
report
date
notabl
although
anticip
antibodi
rais
preferenti
outer
protein
could
readili
expos
immun
cell
antibodi
two
ns
protein
expect
prv
like
gener
viral
inclus
bodi
vib
replic
cycl
common
structur
famili
reovirida
although
function
protein
yet
defin
vib
site
virion
assembl
usual
found
exclus
cytoplasm
spontan
releas
outsid
cell
convers
result
suggest
vib
releas
outsid
cell
probabl
disrupt
prvinfect
cell
report
regard
nt
activ
antibodi
vib
thu
six
structur
two
ns
protein
constitut
candid
viral
protein
seroepidemiolog
studi
especi
posit
ffa
wb
assay
recommend
primari
choic
target
antigen
although
differ
properti
antibodi
recognit
host
speci
must
consid
ie
human
patient
may
develop
antibodi
differ
viral
protein
recogn
mous
infect
model
wb
analysi
discrep
band
pattern
reveal
antiprv
serum
antiha
antibodi
result
indic
antiprv
serum
recogn
particular
site
viral
protein
although
process
prv
protein
synthesi
studi
protein
degrad
truncat
band
reveal
use
antiha
tag
antibodi
may
indic
specif
protein
process
import
biolog
function
analysi
process
viral
protein
could
enabl
character
prv
protein
high
pathogen
prv
human
fulli
investig
owe
limit
number
clinic
case
lack
suitabl
anim
model
establish
anim
model
lethal
lung
infect
prv
could
thu
contribut
primari
examin
pathogen
prv
strain
isol
human
bat
furthermor
recent
develop
plasmidbas
reversegenet
rg
system
prv
kawagishi
et
al
enabl
us
gener
mutant
virus
affect
viru
virul
combin
studi
incorpor
prv
rg
system
lethal
mous
model
establish
current
studi
like
facilit
disclosur
mechan
underli
high
virul
prv
promot
develop
evalu
vaccin
treatment
pathogen
reoviru
